Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 September 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at so that we can update the bibliography.


(PDF, 3MB, 189 pages)


Export 216 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is P  [Clear All Filters]
B. Zhang, de Vries, F., Setakis, E., and van Staa, T. P., The pattern of risk of myocardial infarction in patients taking asthma medication: a study with the General Practice Research Database, J Hypertens, vol. 27, pp. 1485-92, 2009.
C. Millett, Bottle, A., Ng, A., Curcin, V., Molokhia, M., Saxena, S., and Majeed, A., Pay for perfomance and the quality of diabetes management in individuals with and without co-morbid medical conditions, J R Soc Med, vol. 102, pp. 369-77, 2009.
D. J. Humes, Solaymani-Dodaran, M., Fleming, K. M., Simpson, J., Spiller, R. C., and West, J., A population-based study of perforated diverticular disease incidence and associated mortality, Gastroenterology, vol. 136, pp. 1198-205, 2009.
S. Rietbrock, Olson, M., and van Staa, T. P., The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates, Qjm, vol. 102, pp. 35-42, 2009.
S. Turner, Thomas, M., von Ziegenweidt, J., and Price, D., Prescribing trends in asthma: a longitudinal observational study, Arch Dis Child, vol. 94, pp. 16-22, 2009.
R. A. Watts, Al-Taiar, A., Scott, D. G., and Macgregor, A. J., Prevalence and incidence of Wegener's granulomatosis in the UK general practice research database, Arthritis Rheum, vol. 61, pp. 1412-6, 2009.
H. Phatak, Wentworth, C., Sazonov, V., and Burke, T., Prevalence and predictors of lipid abnormalities in patients treated with statins in the UK general practice, Atherosclerosis, vol. 202, pp. 225-33, 2009.
C. Martinez, Sullivan, T., and Hauser, W. A., Prevalence of acute repetitive seizures (ARS) in the United Kingdom, Epilepsy Res, vol. 87, pp. 137-43, 2009.
H. E. Evans, Tsourapas, A., Mercer, C. H., Rait, G., Bryan, S., Hamill, M., Delpech, V., Hughes, G., Brook, G., Williams, T., Johnson, A. M., Singh, S., Petersen, I., Chadborn, T., and Cassell, J. A., Primary care consultations and costs among HIV-positive individuals in UK primary care 1995-2005: a cohort study, Sex Transm Infect, vol. 85, pp. 543-9, 2009.
Y. B. Brauchli, Jick, S. S., Miret, M., and Meier, C. R., Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis, J Invest Dermatol, vol. 129, pp. 2604-12, 2009.
Y. B. Brauchli, Jick, S. S., Miret, M., and Meier, C. R., Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis, Br J Dermatol, vol. 160, pp. 1048-56, 2009.
J. B. Soriano, Visick, G. T., Muellerova, H., Payvandi, N., and Hansell, A. L., Patterns of comorbidities in newly diagnosed COPD and asthma in primary care, Chest, vol. 128, pp. 2099-107, 2005.
A. Ruigomez, Johansson, S., Wallander, M. A., and Rodriguez, L. A. Garcia, Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK, BMC Cardiovasc Disord, vol. 5, p. 20, 2005.
J. M. Gelfand, Weinstein, R., Porter, S. B., Neimann, A. L., Berlin, J. A., and Margolis, D. J., Prevalence and treatment of psoriasis in the United Kingdom: a population-based study, Arch Dermatol, vol. 141, pp. 1537-41, 2005.
D. Mines, Hill, D., Yu, H., and Novelli, L., Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram, Pharmacoepidemiol Drug Saf, vol. 14, pp. 367-72, 2005.
A. G. Wade, Toumi, I., and Hemels, M. E., A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK, Curr Med Res Opin, vol. 21, pp. 631-42, 2005.
W. T. Hamilton, Gallagher, A. M., Thomas, J. M., and White, P. D., The prognosis of different fatigue diagnostic labels: a longitudinal survey, Fam Pract, vol. 22, pp. 383-8, 2005.
A. Gonzalez-Perez and Rodriguez, L. A. Garcia, Prostate cancer risk among men with diabetes mellitus (Spain), Cancer Causes Control, vol. 16, pp. 1055-8, 2005.
[Page last reviewed 6 September 2019]